NCT04585490 2025-05-06Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLCStanford UniversityPhase 3 Recruiting48 enrolled
NCT04971187 2023-08-01Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung CancerM.D. Anderson Cancer CenterPhase 2 Terminated3 enrolled 8 charts